Sunshine Biopharma (SBFM) Assets Average (2011 - 2026)
Sunshine Biopharma's (SBFM) quarterly Assets Average came in at $29.0 million in Q1 2026, down 2.91% YoY from $29.9 million in Q1 2025, and down 5.78% on a QoQ basis from $30.8 million in Q4 2025.
Sunshine Biopharma (SBFM) Assets Average (2011 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 14 years of Assets Average data on file, last reported at $29.0 million in Q1 2026.
- Quarterly Assets Average fell 2.91% year-over-year to $29.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.0 million (down 2.91% YoY) and the FY2025 annual result came in at $30.3 million, up 4.72% from the prior year.
- Assets Average eased to $29.0 million in Q1 2026, from $30.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $41.4 million in Q3 2022 to a low of $7.8 million in Q1 2022.
- A 5-year average of $29.1 million and a median of $29.7 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average surged 1818.4% — and 2023, when it sank 32.34%.
- Tracing SBFM's Assets Average over 5 years: stood at $35.1 million in 2022, then declined by 21.55% to $27.5 million in 2023, then grew by 10.22% to $30.3 million in 2024, then rose by 1.57% to $30.8 million in 2025, then fell by 5.78% to $29.0 million in 2026.
- The last three Assets Average figures came in at $29.0 million (Q1 2026), $30.8 million (Q4 2025), and $31.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | 30.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.78 Mn |
| Mar 31, 2026 | 29.00 Mn |
| Dec 31, 2025 | 30.78 Mn |
| Sep 30, 2025 | 31.73 Mn |
| Jun 30, 2025 | 30.58 Mn |
| Mar 31, 2025 | 29.87 Mn |
| Dec 31, 2024 | 30.31 Mn |
| Sep 30, 2024 | 29.68 Mn |
| Jun 30, 2024 | 30.60 Mn |
| Mar 31, 2024 | 29.62 Mn |
| Dec 31, 2023 | 27.50 Mn |
| Sep 30, 2023 | 28.03 Mn |
| Jun 30, 2023 | 27.70 Mn |
| Mar 31, 2023 | 28.12 Mn |
| Dec 31, 2022 | 35.05 Mn |
| Sep 30, 2022 | 41.43 Mn |
| Jun 30, 2022 | 27.70 Mn |
| Mar 31, 2022 | 7.81 Mn |
| Dec 31, 2021 | 2.35 Mn |
| Sep 30, 2021 | 2.16 Mn |